Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Fumihito Yoshii"'
Autor:
Remi Morimoto, Mutsumi Iijima, Yasuyuki Okuma, Keisuke Suzuki, Fumihito Yoshii, Shigeru Nogawa, Takashi Osada, Kazuo Kitagawa
Publikováno v:
Frontiers in Aging Neuroscience, Vol 15 (2023)
ObjectiveParkinson’s disease (PD) is characterized by various non-motor symptoms (NMS), such as constipation, olfactory disturbance, sleep disturbance, mental disorders, and motor symptoms. This study aimed to investigate factors associated with NM
Externí odkaz:
https://doaj.org/article/335f6210ddee41e4a738a93bb2f8ea17
Publikováno v:
Case Reports in Neurology, Vol 13, Iss 3, Pp 749-754 (2021)
We report a 34-year-old female PARK2 patient presenting with dopa-responsive dystonia (DRD). She noticed difficulty in raising her foot while walking at the age of 24. Her lower limb symptoms were identified as dystonia later, and she was started on
Externí odkaz:
https://doaj.org/article/0f373d36f5974c2f9978861b6a2bc8cd
Publikováno v:
Case Reports in Neurology, Vol 12, Iss 3, Pp 460-465 (2020)
We report an 87-year-old woman with right dorsolateral medullary hemorrhage. She did not show all of the usual symptoms of Wallenberg syndrome and her main symptom was severe dysphagia. Dorsolateral medullary hemorrhage may be overlooked, because it
Externí odkaz:
https://doaj.org/article/e6b64ba06fe14912bb31a2deeca51d36
Publikováno v:
Case Reports in Neurology, Vol 12, Iss 1, Pp 1-6 (2020)
We present a case of primary orthostatic tremor (OT) responsive to dopaminergic medication. The patient was a 62-year-old woman, who had leg tremor on standing for 2 years. No parkinsonian or other neurological signs were observed. Surface electromyo
Externí odkaz:
https://doaj.org/article/b5f2fd9c1f364a689e8b8835b8da877e
Publikováno v:
Case Reports in Neurology, Vol 11, Iss 3, Pp 319-324 (2019)
Foix-Chavany-Marie syndrome (FCMS) is a rare type of pseudobulbar palsy characterized by automatic-voluntary dissociation of movements of the face, tongue, pharynx, and masticatory muscles. Most cases are due to bilateral ischemic lesions of the ante
Externí odkaz:
https://doaj.org/article/e2534afe014f40b6917309267b7dd0b8
Autor:
Mutsumi Iijima, Yasuyuki Okuma, Keisuke Suzuki, Fumihito Yoshii, Shigeru Nogawa, Takashi Osada, Koichi Hirata, Kazuo Kitagawa, Nobutaka Hattori
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0247443 (2021)
BackgroundRapid eye movement sleep behavior disorder (RBD) and olfactory dysfunction are useful for early diagnosis of Parkinson's disease (PD). RBD and severe olfactory dysfunction are also regarded as risk factors for cognitive impairment in PD. Th
Externí odkaz:
https://doaj.org/article/55b19ccf1a1345eb9717e89df5627f0e
Publikováno v:
Case Reports in Neurology, Vol 10, Iss 3, Pp 297-301 (2018)
We present diffusion tensor tractography (DTT) findings in a case of hypertrophic olivary degeneration (HOD) and cerebellar ataxia. A 56-year-old man presented with abnormal ataxic gait and dysarthria. MRI 5 months after onset showed chronic pontine
Externí odkaz:
https://doaj.org/article/c3cb132da1ae45208de44f768c176960
Publikováno v:
Case Reports in Neurology, Vol 9, Iss 3, Pp 267-271 (2017)
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant spinocerebellar degeneration, associated with extended repeats of the trinucleotide CAG in the ATXN2 gene on the long arm of chromosome 12. Magnetic resonance imaging (MRI) of SCA2 showed
Externí odkaz:
https://doaj.org/article/dbc28f6393e947cb9a99ec1abc55d3df
Publikováno v:
Case Reports in Neurology, Vol 8, Iss 3, Pp 243-250 (2016)
We report a 44-year-old female with striatonigral degeneration (SND) who showed wearing-off oscillations after 4 months of levodopa treatment. The patient presented with asymmetric left-side dominant rigidity, and levodopa was effective at first. How
Externí odkaz:
https://doaj.org/article/5f89aaa184ea46e3b7e681737bf8b0d7
Autor:
Eiichiro Nagata, Mieko Ogino, Kounosuke Iwamoto, Yasuhisa Kitagawa, Yasuo Iwasaki, Fumihito Yoshii, Joh-E Ikeda, ALS Consortium Investigators
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0149509 (2016)
OBJECTIVE:Bromocriptine mesylate (BRC), a dopamine D2 receptor agonist has been shown to confer neuroprotection, sustained motor function and slowed disease progression in mouse models of amyotrophic lateral sclerosis (ALS) Here we report a first in
Externí odkaz:
https://doaj.org/article/0f5ffb727004459ea391bc0ee4c2b3bb